We found that ACP52C‐induced growth inhibition occurred regardless of p53 mutation status in general, and GI50 values in mutant p53‐bearing cancers showed only slight deviations among them, which were higher than in p53 wildtype or null cancers (Figure 6B). Here, TP53 is linked to cancer.